ArticleInfectious diseases & immunity2024

Novel Thrice-Weekly Isoniazid plus Rifapentine Short-Course Regimen for the Treatment of Latent Tuberculosis Infection in a Murine Model.

Qiaoling Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.